Quantcast
Search Daily Dose & Film Annex
Loading

BIO SmartBrief

Daily Dose Newsletter

Monday
Jun042012

Islet Sciences Announces Participation at the 2012 American Transplant Congress (ISLT)

Islet Sciences, Inc., (OTCBB: ISLT) is a development-stage biotechnology company with patented technologies focused on transplantation therapy for people with insulin-dependent diabetes. The Company's transplantation technology includes methods for the culturing, isolation, maturation, and immunoprotection (microencapsulation) of islet cells. The Company's mission includes the introduction of commercial products with applications to cell-based replacement therapy in the healthcare marketplace.

The company has announced that it will be presenting at the upcoming 12th Joint Annual Meeting of the American Society of Transplant Surgeons and the American Transplantation (2012 American Transplant Congress).

The event will be held from June 2nd - June 6th at the John B. Hynes Convention Center in Boston, MA. Islet Sciences will present an update on work with their xenotransplantation model for islet transplantation on June 5, 2012 at 5:30 PM ET. Read more at PRNewswire.com
Overview of the American Transplant Congress (ATC), from 2012.atcmeeting.org
  • "To provide a forum for exchange of new scientific and clinical information relevant to solid organ and tissue transplantation.
  • To create an arena for the interchange of ideas regarding care and management of organ and tissue transplant recipients.
  • To facilitate discussions of the socioeconomic, ethical and regulatory issues related to solid organ and tissue transplantation.
A variety of formats are planned that will encourage the exchange of new scientific and clinical information and support an interchange of opinions regarding care and management issues, as well as socioeconomic, ethical, and regulatory issues relevant to organ and tissue transplantation.

Scientific material will be presented through symposia, oral abstracts, concurrent workshops, and poster presentations as well as small group sessions designed for in-depth exploration of both clinical and basic science topics." Read more at 2012.atcmeeting.org

PrintView Printer Friendly Version

EmailEmail Article to Friend

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>
« UPDATE: New Speaker at "The Age Of 'Big Data' In Bioscience Is Here, But Are We Prepared For It?" Panel Discussion in NYC on June 7, 2012 | Main | Prima BioMed to Host Shareholder Briefing ($PBMD) »